BRATTON, D. L.; V. A. FADOK; D. A. RICHTER; J. M. KAILEY; L. A. GUTHRIE; P. M. HENSON.: 'Appearance of phosphatidylserine on apoptotic cells requires calcium- mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase.' J. BIOL. CHEM. vol. 272, 1997, pages 26159 - 26165
ZWAAL, R. F.; P. COMFURIUS; E. M. BEVERS.: 'Surface exposure of phosphatidylserine in pathological cells.' CELL MOL. LIFE SCI. vol. 62, 2005, pages 971 - 988
I sure am glad Dr. Thorpe et al patented Phosphatidlyserine Targeting!
Do we bounce off that 200 DMA?!?!?
I expected a deep V with no AM news.....
Is anyone (in particular) going to show up and start saying "the 200 DMA stopped that downturn in its' tracks" if it continually holds? NAHHHH.
wook
Best of $RESULTS for Humanity, FDA Approval(s), Partner(s) Production, Imaging and MOST IMPORTANTLY!!! Research. Always looking deeper. RIP Dr. Thorpe